Advanced Glycation End Products and Cardiovascular Disease

被引:57
|
作者
Peppa, Melpomeni [1 ]
Raptis, Sotirios A. [1 ]
机构
[1] Attikon Univ Hosp, Res Inst & Diabet Ctr & Hel lenic Natl Diabet Ctr, Dept Internal Medicine Propaedeut 2, Endocrine Unit, Athens, Greece
关键词
Cardiovascular disease; Atherosclerosis; Oxidative stress; Inflammation; Arterial stiffening; Endothelium; Diet; Advanced glycation end products; AGEs; AGE-receptors; AGE-inhibitors; AGE-breakers;
D O I
10.2174/157339908784220732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Advanced glycation end products [AGEs] seem to play an important role for the development and/or progression of CVD mainly through induction of oxidative stress and inflammation. AGEs are a heterogenous group of molecules formed by the nonenzymatic reaction of reducing sugars with amino acids of proteins, lipids and nucleic acids. Recent studies suggest that in addition to those endogenously formed, diet constitutes an important exogenous source of AGEs. Diet-derived AGEs contribute to the whole body AGE pool and the AGE-related pathology. Recent in vitro and in vivo studies revealed significant correlations between diet-derived AGEs and several risk factors and/ or markers of CVD, suggesting the dietary AGEs restriction as a promising therapeutic intervention.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 50 条
  • [31] Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein, G
    Busch, M
    Müller, A
    Wendt, T
    Franke, C
    Niwa, T
    Franke, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : S52 - S56
  • [32] Receptor for Advanced Glycation End Products and Soluble Receptor for Advanced Glycation End Products: A Balancing Act in Chronic Obstructive Pulmonary Disease?
    Sukkar, Maria B.
    Postma, Dirkje S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 893 - 894
  • [33] Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients
    Buraczynska, Monika
    Zaluska, Wojciech
    Buraczynska, Kinga
    Markowska-Gosik, Dorota
    Ksiazek, Andrzej
    HUMAN IMMUNOLOGY, 2015, 76 (11) : 843 - 848
  • [34] Advanced glycation end products and the progressive course of renal disease
    Heidland, A
    Sebekova, K
    Schinzel, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S100 - S106
  • [35] Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
    Jiao, Li
    Taylor, Philip R.
    Weinstein, Stephanie J.
    Graubard, Barry I.
    Virtamo, Jarmo
    Albanes, Demetrius
    Stolzenberg-Solomon, Rachael Z.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1430 - 1438
  • [36] Advanced glycation end products (AGEs) and their involvement in liver disease
    Hyogo, Hideyuki
    Yamagishi, Sho-ichi
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 969 - 972
  • [37] Advanced glycation end products in the pathogenesis of chronic kidney disease
    Rabbani, Naila
    Thornalley, Paul J.
    KIDNEY INTERNATIONAL, 2018, 93 (04) : 803 - 813
  • [38] The role of advanced glycation end products in retinal ageing and disease
    Glenn, Josephine V.
    Stitt, Alan W.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10): : 1109 - 1116
  • [39] Dietary Advanced Glycation End Products and Their Role in Health and Disease
    Uribarri, Jaime
    Dolores del Castillo, Mara
    Pia de la Maza, Mara
    Filip, Rosana
    Gugliucci, Alejandro
    Luevano-Contreras, Claudia
    Macias-Cervantes, Maciste H.
    Markowicz Bastos, Deborah H.
    Medrano, Alejandra
    Menini, Teresita
    Portero-Otin, Manuel
    Rojas, Armando
    Sampaio, Geni Rodrigues
    Wrobel, Kazimierz
    Wrobel, Katarzyna
    Eugenia Garay-Sevilla, Ma
    ADVANCES IN NUTRITION, 2015, 6 (04) : 461 - 473
  • [40] Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease
    Reichert, Stefan
    Triebert, Ulrike
    Santos, Alexander Navarrete
    Hofmann, Britt
    Schaller, Hans-Guenter
    Schlitt, Axel
    Schulz, Susanne
    ATHEROSCLEROSIS, 2017, 266 : 234 - 239